|
Mr. Martin has over 15 years experience in the life sciences industry, both in large, world-class organizations as well as in small successful start-up ventures. Prior to joining Intercept, Mr. Martin served as Chief Business Officer and then Chief Financial Officer at BioXell (BXLN.S), a biopharmaceutical company based in Milan, where he led the company's business development efforts and then took the company public in 2006. Previously, he was Vice President, Global Business Development and Licensing at Novartis Pharma AG, responsible for partnering key assets via co-development and co-commercialization alliances. His experience also includes four years as Vice President Sales & Marketing at Medscape Inc., a healthcare information company which went public on the NASDAQ, and nearly 10 years at SmithKline Beecham where he held various positions in finance, marketing and business development. Mr. Martin received his MBA degree from Harvard Business School and his BA degree from Cornell University. | 